Protective Effect Of Zizyphus Jujuba Fruit Extract Against Paracetamol And Thioacetamide Induced Hepatic Damage In Rats
S Prasanna Kumar, S Basheeruddin Asdaq, N Prem Kumar, M Asad, D Khajuria
Keywords
antioxidants, hepatoprotection, paracetamol, thioacetamide, zizyphus jujuba
Citation
S Prasanna Kumar, S Basheeruddin Asdaq, N Prem Kumar, M Asad, D Khajuria. Protective Effect Of Zizyphus Jujuba Fruit Extract Against Paracetamol And Thioacetamide Induced Hepatic Damage In Rats. The Internet Journal of Pharmacology. 2008 Volume 7 Number 1.
Abstract
Introduction
Liver diseases are considered as one of the serious health problems. Steroids, vaccines and antiviral drugs that are employed as therapy for liver diseases have potential adverse effects especially when administered for long periods (Sehrawat et al., 2006). There is a worldwide trend for use of traditional herbal drugs for the treatment of liver diseases. Several leads from plant sources have been found as potential hepatoprotective agents with diverse chemical structures. Although, a big list of hepatoprotective phytomolecules are reported in the scientific literature, only few were potent against various types of liver damages. Of these, silymarin, andrographolide, neoandrographolide, curcumin, picroside, kutkoside, phyllanthin, hypophyllanthin, and glycyrrhizin have largely attracted the scientific community (Rajesh and Latha, 2004).
In view of the firm belief of Chinese and Indian system of medicine, for hepatoprotective role of
Materials and Methods
Results
Figure 1
Figure 2
Figure 3
Values are mean ± SEM, n = 6, a
Figure 4
Figure 5
Figure 6
Figure 7
Values are mean ± SEM, n = 6, a
Figure 8
Figure 9
Values are mean ± SEM, n = 6, a
Figure 10
Discussion
The present study reveals the hepatoprotective activity of MEZJ against PCM and TAA induced hepatic damage in rats. The results show that MEZJ is effective in low and medium doses (250 mg/kg,
PCM is a commonly used as analgesic and antipyretic drug and is safe in therapeutic doses but produces fatal hepatic necrosis with toxic doses (Mitchell et al., 1973). The toxic effect of PCM is due to oxidative damage induced by its metabolite, N-acetyl-p-benzoquinoneimine, produced by the action of cytochrome P-450 in the liver. This metabolite reacts with reduced glutathione (GSH) to yield non-toxic 3-GS-yl-PCM. Depletion of GSH causes the remaining quinone and other natural endogenous oxygen species to bind to cellular macromolecules leading to cell death (Udem et al., 1997). Damage induced by PCM is accompanied by an increase in the levels of serum biomarker enzymes of liver damage and decreased levels of the same in LTH. Low and medium doses of MEZJ (250 mg/kg and 500 mg/kg) significantly reduced the levels of these biomarkers in serum and there was a corresponding increased level of these biomarkers in LTH when compared to PCM control. The low and medium dose of MEZJ also increased the activities of SOD and catalase in the LTH indicating that they have good antioxidant effect. Drugs having antioxidant activity are also effective in treating PCM induced hepatotoxicity by scavenging the free radicals produced by PCM metabolism, thereby preventing the liver damage induced by both PCM metabolite as well as subsequent depletion of glutathione. Inclination in endogenous antioxidant activities in LTH is an indication of structural integrity and protection to the hepatic cells by prior administration of MEZJ. Elevated activity of catalase in LTH is more beneficial than increase in SOD activity alone because without a simultaneous increase in catalase activity, increased SOD activity may lead to intracellular accumulation of H2O2 with detrimental effects (Das et al., 1995). The PCM induced a significant increase in liver weight, which is due to the blocking of secretion of hepatic triglycerides into the plasma (Yoko et al., 2005).
Toxicity experienced by the liver during TAA poisoning results from the production of a metabolite, thioacetamide
The results of the present study support the traditional claim in both Indian and Chinese medicine that fruits of
Conclusion
The low and medium doses of MEZJ (250 mg/kg and 500 mg/kg) possess good hepatoprotective activity against PCM and TAA induce liver damage, whereas high dose (1000 mg/kg,
Acknowledgement
Authors are thankful to Prof. Dr. Suresh Nagpal